Organogenesis Holdings Inc. provided earnings guidance for the year ending December 31, 2022. For the year ending December 31, 2022, the Company expects net revenue of between $485 million and $515 million, representing an increase of approximately 4% to 10% year-over-year, and 6% to 13% on an adjusted basis3, as compared to net revenue of $468.1 million for the year ended December 31, 2021. Net income of between $56.5 million and $71.5 million and adjusted net income of between $60.2 million and $75.2 million.